GARDEN STAGE LTD (GSIW) Stock Fundamental Analysis

NASDAQ:GSIW • KYG3730L1077

0.1375 USD
-0.01 (-4.65%)
At close: Feb 13, 2026
0.1376 USD
+0 (+0.07%)
After Hours: 2/13/2026, 8:14:09 PM
Fundamental Rating

3

GSIW gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 238 industry peers in the Capital Markets industry. The financial health of GSIW is average, but there are quite some concerns on its profitability. GSIW has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • GSIW had negative earnings in the past year.
  • GSIW had a negative operating cash flow in the past year.
GSIW Yearly Net Income VS EBIT VS OCF VS FCFGSIW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 -2M -4M -6M

1.2 Ratios

  • GSIW has a Return On Assets of -47.75%. This is amonst the worse of the industry: GSIW underperforms 92.44% of its industry peers.
  • GSIW has a Return On Equity of -113.28%. This is amonst the worse of the industry: GSIW underperforms 86.97% of its industry peers.
Industry RankSector Rank
ROA -47.75%
ROE -113.28%
ROIC N/A
ROA(3y)-18.81%
ROA(5y)N/A
ROE(3y)-41.54%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GSIW Yearly ROA, ROE, ROICGSIW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 -100 -200 -300

1.3 Margins

  • GSIW has a better Gross Margin (71.98%) than 79.83% of its industry peers.
  • In the last couple of years the Gross Margin of GSIW has grown nicely.
  • The Profit Margin and Operating Margin are not available for GSIW so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 71.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.82%
GM growth 5YN/A
GSIW Yearly Profit, Operating, Gross MarginsGSIW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025 0 -100 -200 -300

6

2. Health

2.1 Basic Checks

  • The number of shares outstanding for GSIW remains at a similar level compared to 1 year ago.
  • GSIW has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
GSIW Yearly Shares OutstandingGSIW Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 5M 10M 15M
GSIW Yearly Total Debt VS Total AssetsGSIW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 5M 10M 15M

2.2 Solvency

  • GSIW has an Altman-Z score of 0.44. This is a bad value and indicates that GSIW is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.44, GSIW is doing worse than 61.34% of the companies in the same industry.
  • GSIW has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.44
ROIC/WACCN/A
WACCN/A
GSIW Yearly LT Debt VS Equity VS FCFGSIW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 0 5M -5M

2.3 Liquidity

  • A Current Ratio of 1.51 indicates that GSIW should not have too much problems paying its short term obligations.
  • With a decent Current ratio value of 1.51, GSIW is doing good in the industry, outperforming 69.75% of the companies in the same industry.
  • GSIW has a Quick Ratio of 1.51. This is a normal value and indicates that GSIW is financially healthy and should not expect problems in meeting its short term obligations.
  • GSIW has a better Quick ratio (1.51) than 69.75% of its industry peers.
Industry RankSector Rank
Current Ratio 1.51
Quick Ratio 1.51
GSIW Yearly Current Assets VS Current LiabilitesGSIW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 2M 4M 6M 8M 10M

3

3. Growth

3.1 Past

  • The earnings per share for GSIW have decreased strongly by -22.45% in the last year.
  • The Revenue has grown by 185.79% in the past year. This is a very strong growth!
  • Measured over the past years, GSIW shows a very strong growth in Revenue. The Revenue has been growing by 33.26% on average per year.
EPS 1Y (TTM)-22.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.06%
Revenue 1Y (TTM)185.79%
Revenue growth 3Y33.26%
Revenue growth 5YN/A
Sales Q2Q%288.09%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GSIW Yearly Revenue VS EstimatesGSIW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 1M 2M 3M 4M 5M

0

4. Valuation

4.1 Price/Earnings Ratio

  • GSIW reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GSIW Price Earnings VS Forward Price EarningsGSIW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GSIW Per share dataGSIW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.1 -0.2 -0.3 -0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • GSIW does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

GARDEN STAGE LTD

NASDAQ:GSIW (2/13/2026, 8:14:09 PM)

After market: 0.1376 +0 (+0.07%)

0.1375

-0.01 (-4.65%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)01-20
Earnings (Next)07-29
Inst Owners3.49%
Inst Owner Change-12.16%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap30.00M
Revenue(TTM)6.17M
Net Income(TTM)-7.59M
AnalystsN/A
Price TargetN/A
Short Float %0.22%
Short Ratio1.03
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.86
P/FCF N/A
P/OCF N/A
P/B 4.48
P/tB 4.52
EV/EBITDA N/A
EPS(TTM)-0.49
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.03
BVpS0.03
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -47.75%
ROE -113.28%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 71.98%
FCFM N/A
ROA(3y)-18.81%
ROA(5y)N/A
ROE(3y)-41.54%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.82%
GM growth 5YN/A
F-Score3
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 371.09%
Cap/Sales 3.54%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.51
Quick Ratio 1.51
Altman-Z 0.44
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)195.33%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.57%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.06%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)185.79%
Revenue growth 3Y33.26%
Revenue growth 5YN/A
Sales Q2Q%288.09%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-41.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y80.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y83.8%
OCF growth 3YN/A
OCF growth 5YN/A

GARDEN STAGE LTD / GSIW FAQ

What is the fundamental rating for GSIW stock?

ChartMill assigns a fundamental rating of 3 / 10 to GSIW.


What is the valuation status for GSIW stock?

ChartMill assigns a valuation rating of 0 / 10 to GARDEN STAGE LTD (GSIW). This can be considered as Overvalued.


How profitable is GARDEN STAGE LTD (GSIW) stock?

GARDEN STAGE LTD (GSIW) has a profitability rating of 1 / 10.


How financially healthy is GARDEN STAGE LTD?

The financial health rating of GARDEN STAGE LTD (GSIW) is 6 / 10.